Ignacio Lugones

Ignacio Lugones is a seasoned financial executive with extensive experience in corporate finance and strategy. Currently serving as Sr. Corporate Director of FP&A at Knight Therapeutics since November 2023, Ignacio leads the annual budgeting process and financial forecasting. Previously, Ignacio held the position of Country Startup Manager and F&A Director at Laboratorios Biopas from October 2022 to September 2023, where marketing strategies and quantitative analyses were key focuses for business expansion. At Novartis, from November 2015 to October 2022, Ignacio advanced through several roles including Director of Business Franchise Strategic Innovation and CCFO Mexico, where responsibilities included customer engagement and P&L management, as well as overseeing financial operations for the Andean cluster. Ignacio holds a Bachelor's degree in Economics with a focus on Finance from the University of Buenos Aires and a postgraduate degree in Finance from UADE.